Antithrombotic effects in a rat model of aspirin-insensitive arterial thrombosis of desethyl KBT-3022, the main active metabolite of a new antiplatelet agent, KBT-3022

Author： Shimazawa M.   Takiguchi Y.   Umemura K.   Kondo K.   Nakashima M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.328, Iss.2, 1997-09, pp. : 183-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Mechanism of Action of KBT-3022, a New Antiplatelet Agent

By Matsuo K.   Yokota K.   Yamashita A.   Oda M.  

General Pharmacology, Vol. 28, Iss. 2, 1997-02 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite

Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo

By Yamamoto N.   Yokota K.   Yamashita A.   Oda M.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 225-231

Elsevier

Access to resources Recommend Favorite

The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis

By McClanahan T.B.   Hicks G.W.   Morrison A.L.   Peng Y.-W.   Janiczek-Dolphin N.   Mertz T.E.   Sullivan M.E.   Morser J.   Juneau P.L.   Leadley R.  

European Journal of Pharmacology, Vol. 432, Iss. 2, 2001-12 ,pp. : 187-194

Elsevier

Access to resources Recommend Favorite

Antithrombotic activity of AT-1015, a potent 5-HT 2A receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time

By Kihara H.   Koganei H.   Hirose K.   Yamamoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 433, Iss. 2, 2001-12 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite

New Approaches for Antithrombotic Antiplatelet Therapies

By  

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite